Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry  | Primary Offense Type | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $3,000,000 |
| Forest Laboratories, Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $790,000 |
| Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $1,750,000 |
| Genentech Inc. | Roche | pharmaceuticals | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
| General Nutrition Corp. | Harbin Pharmaceutical Group | pharmaceuticals | consumer protection violation | 2002 | FL-AG | $1,000,000 |
| Geneva Pharmaceuticals | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
| Genzyme Corp. | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000 |
| Gilead Sciences | Gilead Sciences | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $250,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2006 | GA-AG | $418,952 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
| GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
| Glenmark Generics Inc. | Glenmark Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2015 | TX-AG | $13,750,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $142,494,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $47,498,000 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Immunex Corp. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
| Inspire Pharmaceuticals | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,000,000 |
| InterMune Inc. | Roche | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000 |
| Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | MT-AG | $5,900,000 |
| Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
| Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $181,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | MULTI-AG | $120,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | WA-AG | $9,900,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $10,000,000 |
| Johnson & Johnson et al. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
| Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $60,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $2,000,000 |
| Johnson and Johnson | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2009 | WV-AG | $4,475,000 |
| King Pharmaceuticals | Pfizer | pharmaceuticals | False Claims Act and related | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $124,000,000 |
| Knoll Pharmaceuticals | AbbVie | pharmaceuticals | consumer protection violation | 2001 | AR-AG | $826,957 |
| Kos Pharmaceuticals | AbbVie | pharmaceuticals | kickbacks and bribery | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,454,432 |
| Lupin Pharmaceuticals | Lupin Limited | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $750,000 |
| McNeil-PPC Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2015 | AL-AG | $500,000 |
| McNeil-PPC, Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2004 | NY-AG | $52,000 |
| Merck & Co. Inc. | Merck | pharmaceuticals | consumer protection violation | 2009 | MULTI-AG | $5,400,000 |
| Merck & Co. | Merck | pharmaceuticals | consumer protection violation | 2008 | MULTI-AG | $58,000,000 |
| Merck & Co., Inc. | Merck | pharmaceuticals | False Claims Act and related | 2011 | MA-AG | $24,000,000 |
| Merck and Company, Inc. | Merck | pharmaceuticals | False Claims Act and related | 2011 | WI-AG | $4,250,000 |
| Merck KGaA | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
| Merck Sharp & Dohme Corp | Merck | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $28,000,000 |
| Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $1,600,000 |
| Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $6,000,000 |
| Mylan Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $465,000,000 |
| Mylan Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
| Mylan Laboratories et al. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
| Mylan Laboratories Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
| Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $625,000 |
| Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2011 | KY-AG | $6,500,000 |
| Mylan Pharmaceuticals, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000 |
| Mylan Specialty L.P. | Viatris | pharmaceuticals | consumer protection violation | 2013 | OR-AG | $250,000 |
| Novartis | Novartis | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
| Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | False Claims Act and related | 2013 | ID-AG | $750,000 |
| Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $2,750,000 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | kickbacks and bribery | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $83,129,754 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
| Novartis Pharmaceuticals | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
| Novo Nordisk Inc. | Novo Holdings A/S | pharmaceuticals | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,320,963 |
| Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516 |
| Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,400,000 |
| OSI Pharmaceuticals LLC | Astellas Pharma | pharmaceuticals | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
| Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | pharmaceuticals | consumer protection violation | 2007 | VT-AG | $10,000 |
| Par Pharmaceutical | Endo International | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
| Par Pharmaceutical Co. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000 |
| Par Pharmaceutical Cos., Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $1,700,000 |
| Par Pharmaceutical Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | KY-AG | $4,500,000 |
| Par Pharmaceutical, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $500,000 |
| Par Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | MULTI-AG | $154,000,000 |
| Pernix Therapeutics | Currax Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $800,000 |
| Perrigo | Perrigo | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $2,000,000 |
| Perrigo Company | Perrigo | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
| Pfizer | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2003 | MULTI-AG | $6,000,000 |
| Pfizer | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $35,000,000 |
| Pfizer | Pfizer | pharmaceuticals | consumer protection violation | 2019 | OR-AG | $975,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2002 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $21,084,700 |
| Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
| Pfizer Inc. and Pharmacia Corp. | Pfizer | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $2,900,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | consumer protection violation | 2018 | NY-AG | $700,000 |
| Pfizer, Inc. | Pfizer | pharmaceuticals | kickbacks and bribery | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $331,485,170 |
| Pfizer, Inc. | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2012 | OR-AG | $3,340,000 |
| Pfizer, Inc. and Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $8,200,000 |
| Pharmacia Corp. | Pfizer | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $400,000 |
| Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2011 | NY-AG | $2,500,000 |
| Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2013 | WI-AG | $29,453,247 |
| Purdue Frederick Co. | Purdue Pharma | pharmaceuticals | False Claims Act and related | 2008 | TX-AG | $1,600,000 |
| Purdue Frederick Company, Inc. and Purdue Pharma, L.P. | Purdue Pharma | pharmaceuticals | Controlled Substances Act violation | 2007 | NV-AG | $1,047,787 |
| Purdue Pharma | Purdue Pharma | pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | MULTI-AG | $19,500,000 |
| Purdue Pharma | Purdue Pharma | pharmaceuticals | drug or medical equipment safety violation | 2015 | KY-AG | $24,000,000 |
| Purdue Pharma, L.P. | Purdue Pharma | pharmaceuticals | Controlled Substances Act violation | 2015 | NY-AG | $75,000 |
| Purepac Pharmaceutical Co. | Pfizer | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $600,000 |
| Purepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC | Pfizer | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
